Literature DB >> 18777554

Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis.

Aaron Schein1, Cathleen Enriquez, Thomas D Coates, John C Wood.   

Abstract

PURPOSE: To study the pattern, etiology, and significance of renal iron accumulation in chronically transfused sickle cell disease (SCD) and thalassemia major (TM) patients using magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Magnetic resonance imaging (MRI) was performed in 75 SCD patients, 73 TM patients, and 16 healthy controls. Multiecho gradient echo protocols were used to measure T2* reciprocals (R2*) in the kidney, liver, and heart. Kidney R2* was compared to tissue iron estimates, serum iron markers, and surrogates of intravascular hemolysis by univariate regression.
RESULTS: Mean R2* in SCD patients was 55.3+/-45.3 Hz, compared with 22.1+/-11 Hz in TM patients and 21.3+/-5.8 Hz in control subjects (P<0.001). Kidney R2* decreased with advancing age (R2=0.09, P<0.02). Kidney R2* correlated strongly with increased serum lactate dehydrogenase levels found in SCD (R2=0.55, P<0.001), but was independent of hepatic iron concentration and cardiac R2*. Kidney R2* did not correlate with blood pressure, creatinine, cardiac index, or right and left ejection fraction.
CONCLUSION: Intravascular hemolysis, not chronic transfusion, causes renal hemosiderosis in SCD. Prospective trials are necessary to determine whether kidney R2* is a biomarker for hemolysis-mediated vascular complications in SCD. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777554      PMCID: PMC2597353          DOI: 10.1002/jmri.21490

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  42 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Renal function in pediatric patients with beta-thalassemia major.

Authors:  B Aldudak; A Karabay Bayazit; A Noyan; A Ozel; A Anarat; I Sasmaz; Y Kilinç; E Gali; R Anarat; N Dikmen
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

Review 3.  Physiology and pathophysiology of heme: implications for kidney disease.

Authors:  Michal J Tracz; Jawed Alam; Karl A Nath
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

Review 4.  Sickle cell nephropathy.

Authors:  P Saborio; J I Scheinman
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

5.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

6.  Hemosiderin deposition on the renal cortex by mechanical hemolysis due to malfunctioning prosthetic cardiac valve: report of MR findings in two cases.

Authors:  J W Lee; S H Kim; C J Yoon
Journal:  J Comput Assist Tomogr       Date:  1999 May-Jun       Impact factor: 1.826

7.  Renal function in adult beta-thalassemia/Hb E disease.

Authors:  L Ong-ajyooth; P Malasit; S Ong-ajyooth; S Fucharoen; P Pootrakul; S Vasuvattakul; N Siritanaratkul; S Nilwarangkur
Journal:  Nephron       Date:  1998       Impact factor: 2.847

Review 8.  Iron-chelating therapy and the treatment of thalassemia.

Authors:  N F Olivieri; G M Brittenham
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

9.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

10.  Global epidemiology of hemoglobin disorders.

Authors:  M Angastiniotis; B Modell
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

View more
  27 in total

Review 1.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 2.  Use of magnetic resonance imaging to monitor iron overload.

Authors:  John C Wood
Journal:  Hematol Oncol Clin North Am       Date:  2014-08       Impact factor: 3.722

3.  MRI-based R2* mapping in patients with suspected or known iron overload.

Authors:  Emre Aslan; Jack W Luo; An Lesage; Philippe Paquin; Milena Cerny; Anne Shu-Lei Chin; Damien Olivié; Guillaume Gilbert; Denis Soulières; An Tang
Journal:  Abdom Radiol (NY)       Date:  2021-01-02

Review 4.  MR imaging assessment and quantification of liver iron.

Authors:  Manuela França; João Gomes Carvalho
Journal:  Abdom Radiol (NY)       Date:  2020-11

5.  Diffusion tensor imaging MRI of sickle cell kidney disease: initial results and comparison with iron deposition.

Authors:  Shannon B Donnola; Connie M Piccone; Lan Lu; Joshua Batesole; Jane Little; Katherine M Dell; Chris A Flask
Journal:  NMR Biomed       Date:  2018-01-19       Impact factor: 4.044

6.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

7.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

Review 8.  Iron metabolism in the pathogenesis of iron-induced kidney injury.

Authors:  A M F Martines; R Masereeuw; H Tjalsma; J G Hoenderop; J F M Wetzels; D W Swinkels
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

9.  Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.

Authors:  Nilesh R Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland Fischer; Roger Williams; Paul Harmatz; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

10.  Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia.

Authors:  Dima Hamideh; Vimal Raj; Thomas Harrington; Hua Li; Emilio Margolles; Folasade Amole; Monica Garcia-Buitrago; Phillip Ruiz; Gaston Zilleruelo; Ofelia Alvarez
Journal:  Pediatr Nephrol       Date:  2014-06-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.